Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Wegovy FlexTouch 1mg/0.75ml inj 3ml pre-filled pens
0601023AWBDADAI
|
Wegovy | Semaglutide | Endocrine System | 430 |
|
Wegovy FlexTouch 0.5mg/0.37ml inj 1.5ml pre-filled pens
0601023AWBDAAAB
|
Wegovy | Semaglutide | Endocrine System | 420 |
|
Wegovy FlexTouch 0.25mg/0.37ml inj 1.5ml pre-filled pens
0601023AWBDABAG
|
Wegovy | Semaglutide | Endocrine System | 316 |
|
Wegovy FlexTouch 2.4mg/0.75ml inj 3ml pre-filled pens
0601023AWBDAEAJ
|
Wegovy | Semaglutide | Endocrine System | 227 |
|
Wegovy FlexTouch 1.7mg/0.75ml inj 3ml pre-filled pens
0601023AWBDACAH
|
Wegovy | Semaglutide | Endocrine System | 206 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.